Blog Posts
Explore timely perspectives from WCG’s clinical trial operations and scientific leaders.
WCG Clinical | Insights
The FDA’s Updated IRB Bioresearch Monitoring (BIMO) Inspection Manual
Blog Posts
WCG Clinical | Insights
Protocol Deviations Explained: Understanding the FDA’s Draft Guidance
Blog Posts
WCG Clinical | Insights
Bulk Data Transfers: What Researchers Need to Know About Executive Order 14117 and 28 CFR Part 202
Blog Posts
WCG Clinical | Insights
Ensuring Representative US Enrollment in Oncology Clinical Trials: Navigating the Rising Tide of Regulatory Scrutiny
Blog Posts
WCG Clinical | Insights
Celebrating 25 Years of IBC Reviews: Pioneering the Past, Shaping the Future
Blog Posts
WCG Clinical | Insights
Eyewash Stations & Gene Transfer Studies: NIH Guidelines Explained
Blog Posts
WCG Clinical | Insights
How Long Should Eyes Be Flushed After Exposure?
Blog Posts
WCG Clinical | Insights
FDA Guidance on AI-Enabled Devices: Transparency, Bias, & Lifecycle Oversight
Blog Posts
WCG Clinical | Insights
Best Practices for Protecting Non-Participants in Human Gene Transfer Clinical Trials
Blog Posts
WCG Clinical | Insights